On World Sepsis Day we renew our commitment to raise awareness of sepsis and increase efforts to reduce the worldwide burden of this life-threatening condition. Latest estimates pose that about 11 million people each year because of sepsis and evidence from GLOSS has shown the significant impact sepsis has on maternal mortality and morbidity. New evidence suggests that about one third of all births from women with infection were severe perinatal outcomes (neonatal near-miss or perinatal death).
Please help us amplify the messages around maternal sepsis and share the GLOSS-related publications widely:
Also visit our Resources page for other materials developed for the study and campaign.
A new paper on an analysis of GLOSS participating facilities was published in Lancet Global Health. It showed that availability of resources and services necessary to prevent, identify, and manage maternal infections in facilities that participated in GLOSS did not always result in better maternal outcomes. In fact, it showed that individual women’s characteristics known to be associated with poor maternal outcomes, such as pre-existing conditions, are more probable predictors of severe outcomes than characteristics of a health facility (e.g. medical supplies and equipment).
To read the full article, please click here.
Remember to visit our resources page for other resources to use in your facilities.
Background: Infections are among the leading causes of maternal mortality and morbidity. The Global Maternal Sepsis and Neonatal Initiative, launched in 2016 by WHO and partners, sought to reduce the burden of maternal infections and sepsis and was the basis upon which the Global Maternal Sepsis Study (GLOSS) was implemented in 2017. In this Article, we aimed to describe the availability of facility resources and services and to analyse their association with maternal outcomes.
Methods: GLOSS was a facility-based, prospective, 1-week inception cohort study implemented in 713 health-care facilities in 52 countries and included 2850 hospitalised pregnant or recently pregnant women with suspected or confirmed infections. All women admitted for or in hospital with suspected or confirmed infections during pregnancy, childbirth, post partum, or post abortion at any of the participating facilities between Nov 28 and Dec 4 were eligible for inclusion. In this study, we included all GLOSS participating facilities that collected facility-level data (446 of 713 facilities). We used data obtained from individual forms completed for each enrolled woman and their newborn babies by trained researchers who checked the medical records and from facility forms completed by hospital administrators for each participating facility. We described facilities according to country income level, compliance with providing core clinical interventions and services according to women’s needs and reported availability, and severity of infection-related maternal outcomes. We used a logistic multilevel mixed model for assessing the association between facility characteristics and infection-related maternal outcomes.
Findings: We included 446 facilities from 46 countries that enrolled 2560 women. We found a high availability of most services and resources needed for obstetric care and infection prevention. We found increased odds for severe maternal outcomes among women enrolled during the post-partum or post-abortion period from facilities located in low-income countries (adjusted odds ratio 1·84 [95% CI 1·05–3·22]) and among women enrolled during pregnancy or childbirth from non-urban facilities (adjusted odds ratio 2·44 [1·02–5·85]). Despite compliance being high overall, it was low with regards to measuring respiratory rate (85 [24%] of 355 facilities) and measuring pulse oximetry (184 [57%] of 325 facilities).
Interpretation: While health-care facilities caring for pregnant and recently pregnant women with suspected or confirmed infections have access to a wide range of resources and interventions, worse maternal outcomes are seen among recently pregnant women located in low-income countries than among those in higher-income countries; this trend is similar for pregnant women. Compliance with cost-effective clinical practices and timely care of women with particular individual characteristics can potentially improve infection-related maternal outcomes.